Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 314
Magel, V, Blum, J, Dolde, X, Leisner, H, Grillberger, K, Khalidi, H, Gardner, I, Ecker, GF, Pallocca, G, Dreser, N & Leist, M 2024, 'Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants', Cells, vol. 13, no. 24, 2057. https://doi.org/10.3390/cells13242057
Li, E, Boujeddaine, N, Houtman, MJC, Maas, RGC, Sluijter, JPG, Ecker, GF, Stary-Weinzinger, A, van Ham, WB & van der Heyden, MAG 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology, vol. 182, no. 3, pp. 633-650. https://doi.org/10.1111/bph.17377
Ortega-Vallbona, R, Palomino-Schätzlein, M, Tolosa, L, Benfenati, E, Ecker, GF, Gozalbes, R & Serrano-Candelas, E 2024, 'Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study', International Journal of Molecular Sciences, vol. 25, no. 20, 11154. https://doi.org/10.3390/ijms252011154
Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599
Granulo, N, Sosnin, S, Digles, D & Ecker, GF 2024, 'The macrocycle inhibitor landscape of SLC‐transporter', Molecular Informatics, vol. 43, no. 5, e202300287. https://doi.org/10.1002/minf.202300287
Activities
Showing entries 41 - 45 out of 203
Analyse der molekularen Basis der GABA Transporter Inhibition
Andreas Jurik
,
Barbara Zdrazil
,
Marion Holy
,
Harald H. Sitte
,
Gerhard Ecker
47.Wissenschaftliche Fortbildungswoche der Österreichischen Apothekerkammer
Conference,
Poster presentation
..2014 - ..2014
Probing mGAT1/ mGAT2 selectivity by a novel series of tool compounds
Andreas Jurik
,
Rasmus P Clausen
,
Thomas Stockner
,
Harald H. Sitte
,
Gerhard Ecker
7th SFB Annual Symposium
Conference,
Poster presentation
..2014 - ..2014
Snapshot pharmacokinetic study in mice of two piperine analogues with gamma-aminobutyric acid type A (GABAA) receptor modulatory properties
Mouhssin Oufir
,
Angela Schöffmann
,
Laurin Wimmer
,
Daria Goldmann
,
Sophia Khom
,
Juliane Hintersteiner
,
Igor Baburin
,
Thomas Schwarz
,
Michael Hintersteininger
,
Peter Pakfeifer
,
Thomas Erker
,
Gerhard Ecker
,
Marko Mihovilovic
,
Steffen Hering
,
Matthias Hamburger
Swiss Pharma Day 2014
Conference,
Poster presentation
..2014 - ..2014
Experimental data guided docking for elucidating the molecular basis of drug-transporter interaction
Gerhard Ecker
Talk or oral contribution
18.12.2013 - 18.12.2013
Experimental data guided docking allows to elucidate the molecular basis of drug-transporter interaction
Gerhard Ecker
Pharma Indochina VIII
Conference,
Talk or oral contribution
4.12.2013 - 4.12.2013